Cancer Research AACR Legacy EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Studeny, M.
Right arrow Articles by Andreeff, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Studeny, M.
Right arrow Articles by Andreeff, M.
[Cancer Research 62, 3603-3608, July 1, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Bone Marrow-derived Mesenchymal Stem Cells as Vehicles for Interferon-ß Delivery into Tumors1

Matus Studeny, Frank C. Marini, Richard E. Champlin, Claudia Zompetta, Isaiah J. Fidler and Michael Andreeff2

Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation [M. S., F. C. M., R. E. C., C. Z., M. A.], and Department of Cancer Biology [I. J. F.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Molecules that physiologically control cell proliferation are often produced locally in tissues and are rapidly destroyed when they enter circulation. This allows local effects while avoiding interference with other systems. Unfortunately, it also limits the therapeutic use of these molecules via systemic delivery. We here demonstrate that, for the purpose of anticancer therapy, bone marrow-derived mesenchymal stem cells (MSCs) can produce biological agents locally at tumor sites. We show that the tumor microenvironment preferentially promotes the engraftment of MSCs as compared with other tissues. MSCs with forced expression of IFN-ß inhibited the growth of malignant cells in vivo. Importantly, this effect required the integration of MSCs into the tumors and could not be achieved by systemically delivered IFN-ß or by IFN-ß produced by MSCs at a site distant from the tumors. Our results indicate that MSCs may serve as a platform for delivery of biological agents in tumors.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
M. E.J. Reinders, W. E. Fibbe, and T. J. Rabelink
Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation
Nephrol. Dial. Transplant., October 26, 2009; (2009) gfp552v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Mazar, M. Thomas, L. Bezrukov, A. Chanturia, G. Pekkurnaz, S. Yin, S. A. Kuznetsov, P. G. Robey, and J. Zimmerberg
Cytotoxicity Mediated by the Fas Ligand (FasL)-activated Apoptotic Pathway in Stem Cells
J. Biol. Chem., August 14, 2009; 284(33): 22022 - 22028.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Z. Li, Y. Liu, S. Tuve, Y. Xun, X. Fan, L. Min, Q. Feng, N. Kiviat, H.-P. Kiem, M. L. Disis, et al.
Toward a stem cell gene therapy for breast cancer
Blood, May 28, 2009; 113(22): 5423 - 5433.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. R. Loebinger, A. Eddaoudi, D. Davies, and S. M. Janes
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Cancer Res., May 15, 2009; 69(10): 4134 - 4142.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. B. Coffelt, F. C. Marini, K. Watson, K. J. Zwezdaryk, J. L. Dembinski, H. L. LaMarca, S. L. Tomchuck, K. H. zu Bentrup, E. S. Danka, S. L. Henkle, et al.
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells
PNAS, March 10, 2009; 106(10): 3806 - 3811.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Ganta, D. Chiyo, R. Ayuzawa, R. Rachakatla, M. Pyle, G. Andrews, M. Weiss, M. Tamura, and D. Troyer
Rat Umbilical Cord Stem Cells Completely Abolish Rat Mammary Carcinomas with No Evidence of Metastasis or Recurrence 100 Days Post-Tumor Cell Inoculation
Cancer Res., March 1, 2009; 69(5): 1815 - 1820.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. J. Mishra, P. J. Mishra, J. W. Glod, and D. Banerjee
Mesenchymal Stem Cells: Flip Side of the Coin
Cancer Res., February 15, 2009; 69(4): 1255 - 1258.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
C. Kyriakou, N. Rabin, A. Pizzey, A. Nathwani, and K. Yong
Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model
Haematologica, October 1, 2008; 93(10): 1457 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
W. Du, N. Hozumi, M. Sakamoto, J.-i. Hata, and T. Yamada
Reconstitution of Schwannian Stroma in Neuroblastomas Using Human Bone Marrow Stromal Cells
Am. J. Pathol., October 1, 2008; 173(4): 1153 - 1164.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Ohtaki, J. H. Ylostalo, J. E. Foraker, A. P. Robinson, R. L. Reger, S. Shioda, and D. J. Prockop
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses
PNAS, September 23, 2008; 105(38): 14638 - 14643.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
M. R. Loebinger, E. K. Sage, and S. M. Janes
Mesenchymal Stem Cells as Vectors for Lung Disease
Proceedings of the ATS, August 15, 2008; 5(6): 711 - 716.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Eliopoulos, M. Francois, M.-N. Boivin, D. Martineau, and J. Galipeau
Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy
Cancer Res., June 15, 2008; 68(12): 4810 - 4818.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. J. Mishra, P. J. Mishra, R. Humeniuk, D. J. Medina, G. Alexe, J. P. Mesirov, S. Ganesan, J. W. Glod, and D. Banerjee
Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells
Cancer Res., June 1, 2008; 68(11): 4331 - 4339.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. H. Klopp, E. L. Spaeth, J. L. Dembinski, W. A. Woodward, A. Munshi, R. E. Meyn, J. D. Cox, M. Andreeff, and F. C. Marini
Tumor Irradiation Increases the Recruitment of Circulating Mesenchymal Stem Cells into the Tumor Microenvironment
Cancer Res., December 15, 2007; 67(24): 11687 - 11695.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. J. Nauta and W. E. Fibbe
Immunomodulatory properties of mesenchymal stromal cells
Blood, November 15, 2007; 110(10): 3499 - 3506.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R.M. Dwyer, S.M. Potter-Beirne, K.A. Harrington, A.J. Lowery, E. Hennessy, J.M. Murphy, F.P. Barry, T. O'Brien, and M.J. Kerin
Monocyte Chemotactic Protein-1 Secreted by Primary Breast Tumors Stimulates Migration of Mesenchymal Stem Cells
Clin. Cancer Res., September 1, 2007; 13(17): 5020 - 5027.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Kucerova, V. Altanerova, M. Matuskova, S. Tyciakova, and C. Altaner
Adipose Tissue-Derived Human Mesenchymal Stem Cells Mediated Prodrug Cancer Gene Therapy
Cancer Res., July 1, 2007; 67(13): 6304 - 6313.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. J. Prockop and S. D. Olson
Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions
Blood, April 15, 2007; 109(8): 3147 - 3151.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
X.-c. Chen, R. Wang, X. Zhao, Y.-q. Wei, M. Hu, Y.-s. Wang, X.-w. Zhang, R. Zhang, L. Zhang, B. Yao, et al.
Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs
Carcinogenesis, December 1, 2006; 27(12): 2434 - 2441.
[Abstract] [Full Text] [PDF]

Home page
 ASH ANNUAL MEETING ABSTRACTSHome page
M. Andreeff, J. Dembinski, B. M. Hall, M. Studeny, X. Ling, M. Cabreira-Hansen, A. K. Sasser, T. McQueen, F. Lang, and F. C. Marini
Mesenchymal Stem Cells Selectively Engraft into Tumor Stroma and Produce Potent Antitumor Proteins In Situ.
Blood (ASH Annual Meeting Abstracts), November 16, 2006; 108(11): 352 - 352.
[Abstract] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. H. Lee, M. J. Seo, R. L. Reger, J. L. Spees, A. A. Pulin, S. D. Olson, and D. J. Prockop
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice
PNAS, November 14, 2006; 103(46): 17438 - 17443.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Ikehara, T. Niwa, L. Biao, S. K. Ikehara, N. Ohashi, T. Kobayashi, Y. Shimizu, N. Kojima, and H. Nakanishi
A Carbohydrate Recognition-Based Drug Delivery and Controlled Release System using Intraperitoneal Macrophages as a Cellular Vehicle.
Cancer Res., September 1, 2006; 66(17): 8740 - 8748.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Sports. Med.Home page
M Ramirez, A Lucia, F Gomez-Gallego, J Esteve-Lanao, A Perez-Martinez, C Foster, A L Andreu, M A Martin, L Madero, J Arenas, et al.
Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury
Br. J. Sports Med., August 1, 2006; 40(8): 719 - 722.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Stagg, S. Pommey, N. Eliopoulos, and J. Galipeau
Interferon-{gamma}-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell
Blood, March 15, 2006; 107(6): 2570 - 2577.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Komarova, Y. Kawakami, M. A. Stoff-Khalili, D. T. Curiel, and L. Pereboeva
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses.
Mol. Cancer Ther., March 1, 2006; 5(3): 755 - 766.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
P. Bosch, S. L. Pratt, and S. L. Stice
Isolation, Characterization, Gene Modification, and Nuclear Reprogramming of Porcine Mesenchymal Stem Cells
Biol Reprod, January 1, 2006; 74(1): 46 - 57.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Eliopoulos, J. Stagg, L. Lejeune, S. Pommey, and J. Galipeau
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice
Blood, December 15, 2005; 106(13): 4057 - 4065.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-C. Hung, W.-P. Deng, W. K. Yang, R.-S. Liu, C.-C. Lee, T.-C. Su, R.-J. Lin, D.-M. Yang, C.-W. Chang, W.-H. Chen, et al.
Mesenchymal Stem Cell Targeting of Microscopic Tumors and Tumor Stroma Development Monitored by Noninvasive In vivo Positron Emission Tomography Imaging
Clin. Cancer Res., November 1, 2005; 11(21): 7749 - 7756.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Krampera, A. Pasini, A. Rigo, M. T. Scupoli, C. Tecchio, G. Malpeli, A. Scarpa, F. Dazzi, G. Pizzolo, and F. Vinante
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation
Blood, July 1, 2005; 106(1): 59 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Nakamizo, F. Marini, T. Amano, A. Khan, M. Studeny, J. Gumin, J. Chen, S. Hentschel, G. Vecil, J. Dembinski, et al.
Human Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Cancer Res., April 15, 2005; 65(8): 3307 - 3318.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
F. Marini, M. Studeny, and M. Andreeff
RESPONSE: Re: Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents
J Natl Cancer Inst, April 6, 2005; 97(7): 541 - 542.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Studeny, F. C. Marini, J. L. Dembinski, C. Zompetta, M. Cabreira-Hansen, B. N. Bekele, R. E. Champlin, and M. Andreeff
Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents
J Natl Cancer Inst, November 3, 2004; 96(21): 1593 - 1603.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Kinnaird, E. Stabile, M.S. Burnett, M. Shou, C.W. Lee, S. Barr, S. Fuchs, and S.E. Epstein
Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms
Circulation, March 30, 2004; 109(12): 1543 - 1549.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Djouad, P. Plence, C. Bony, P. Tropel, F. Apparailly, J. Sany, D. Noel, and C. Jorgensen
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Blood, November 15, 2003; 102(10): 3837 - 3844.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.